MAR 20, 2020 9:12 AM PDT

4 Potential Treatments for SARS-CoV-2 Currently Under Testing

WRITTEN BY: Annie Lennon

Currently, no medicine nor vaccine has been approved as effective for the prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite this, around the world there are many drugs currently under trial. Here are the top four potential treatments recommended by both Chinese experts and Korean physicians. 

Remdesivir, a novel antiviral drug, is so far a strong candidate. Although results from a clinical trial carried out in China are only expected to become available in April, preclinical trials have shown its efficacy against the virus and that it has a high genetic barrier to resistance. Furthermore, previous data has shown that the drug is able to inhibit activity in other coronavirus strains including the 2002 SARS-CoV and MERS-CoV (Middle Eastern Respiratory Syndrome). 

Sofosbuvir taken in combination with ribavirin is another promising candidate. Although no results from clinical trials are available yet, early results from a molecular docking experiment have shown that the drug combination is able to bind to SARS-CoV-2 molecules. This means that it may also be effective in treating infections caused by the virus. 

Lopinavir, ritonavir taken alongside ribavirin and corticosteroids has also shown promise as a treatment option. Currently being trialed among patients with SARS-CoV-2 who have not developed acute respiratory distress syndrome, results so far look positive. Whereas 6.3% of those being treated with ribavirin and corticosteroids alone died at day 21, with 22.5% meeting the criteria for severe hypoxemia (an abnormally low level of oxygen in the blood), for those treated with lopinavir and ritonavir alongside ribavirin and corticosteroids, just 2.4% met the criteria for severe hypoxemia, whereas none died within the same timeframe.

Interferon alfacon-1 taken together with corticosteroids is another treatment with potential. Under an open-label trial comparing patients with the drug combination and those taking corticosteroids alone, so far, researchers have seen positive results. In particular, those in the interferon alfacon-1 group saw abnormalities in their lungs reduce by 50% in just 4 days, whereas the same took 9 days in the group taking corticosteroids alone. Moreover, the group on interferon alfacon-1 had better oxygen saturation in their blood sooner and thus required supplemental oxygen for significantly less time than those in the control group. Resolutions of fevers however were similar between both groups. 



Sources: El Sevier

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
SEP 30, 2021
Drug Discovery & Development
Exosome delivery of an anti-HIV drug to the brain
SEP 30, 2021
Exosome delivery of an anti-HIV drug to the brain
The body has a remarkable ability to prevent foreign objects, such as toxins or other pathogens, from entering the brain ...
OCT 18, 2021
Health & Medicine
Emerging Research on Delta 8 THC
OCT 18, 2021
Emerging Research on Delta 8 THC
Delta-8-tetrahydrocannabinol is a cannabinoid derived from the hemp plant. It is one of the more prominent compounds, bu ...
OCT 20, 2021
Microbiology
Bacteria From Cats Could Help Treat Infections
OCT 20, 2021
Bacteria From Cats Could Help Treat Infections
Many animals, including humans and cats, harbor huge colonies of microbes, which may live in places like the skin, or th ...
OCT 25, 2021
Health & Medicine
Latest Cannabis Extraction Developments
OCT 25, 2021
Latest Cannabis Extraction Developments
In response to the growing demand for concentrates, cannabis product manufacturers are exploring new technological advan ...
NOV 19, 2021
Genetics & Genomics
Transcriptomics Method Can Reveal Genes Behind Venom Production
NOV 19, 2021
Transcriptomics Method Can Reveal Genes Behind Venom Production
Some of our best medications have come from nature. For years, researchers have been studying the properties of differen ...
DEC 04, 2021
Cannabis Sciences
Modulating the CBD/Apelinergic System Interaction as a COVID-19 Treatment?
DEC 04, 2021
Modulating the CBD/Apelinergic System Interaction as a COVID-19 Treatment?
Although CBD has long been implicated as an anti-inflammatory agent, it is only within the past few decades that it has ...
Loading Comments...